| Betterchem |

|
|
|
| FDA approval activities
for this prescription drug:
Spectracef (Cefditoren Pivoxil) Tablets, 200 mg, TAP Pharmaceutical Products NDA 21-222/S1 8/21/02 8/26/02 8/22/02 Spectracef (Cefditoren Pivoxil) Tablets, 200 mg TAP Pharmaceutical Products NDA 21-222 8/29/01 11/5/01 11/5/01 12/7/01 Spectracef Indications: Treatment of acute exacerbation of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections. |
© 2009 Betterchem.com
|